TYMS and colonic neoplasm: In this part of the study, it is hoped that a colon-targeted drug delivery system of LV can be successfully constructed to target colon tumor cells, to increase its uptake by colon tumor cells, and to better bind to 5-FU metabolites and TS to enhance the inhibition of tumor cells.